about
A novel classification system to address financial impact and referral decisions for bile duct injury in laparoscopic cholecystectomy.Surgical resection for hilar cholangiocarcinoma: experience improves resectabilityEvaluation of stapler hepatectomy during a laparoscopic liver resectionMulti-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resectionRestrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity.Evaluation of quality of life following placement of self-expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for esophageal cancer.Management of benign hepatic tumors.Laparoscopic liver resection: an examination of our first 300 patients.Safety and efficacy of hepatectomy for colorectal metastases in the elderly.BK viral disease in renal transplantation.Analysis of BK viral infection after alemtuzumab induction for renal transplant.Open repair of blunt thoracic aortic injury remains relevant in the endovascular era.The contribution of donor quality to differential graft survival in African American and Caucasian renal transplant recipients.A review of the United States experience with combined heart-liver transplantation.The impact of recipient obesity on outcomes after renal transplantation.To pump or not to pump: a comparison of machine perfusion vs cold storage for deceased donor kidney transplantation.Etiology and incidence of pediatric gallbladder disease.Laparoscopic component separation reduces postoperative wound complications but does not alter recurrence rates in complex hernia repairs.The prevalence and impact of prescription controlled substance use among injured patients at a Level I trauma center.Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis.Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity.MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.Improving clinical productivity in an academic surgical practice through transparency.A resident perspective on increasing duty-hour limitations.Impact of withdrawal of care and futile care on trauma mortality.Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures.Unintentional perioperative hypothermia is associated with severe complications and high mortality in elective operations.Laparoscopic left hemihepatectomy a consideration for acceptance as standard of care.ReplyIs laparoscopic repeat hepatectomy feasible? A tri-institutional analysisManagement of diffuse hepatocellular carcinoma (≧ 10 Lesions) with doxorubicin-loaded DC beads is a safe and effective treatment optionKidney transplantation alone in ESRD patients with hepatitis C cirrhosisLaparoscopic versus open resection of hepatic colorectal metastasesA literature-based cost analysis of tissue plasminogen activator for prevention of biliary stricture in donation after circulatory death liver transplantationAn analysis of unplanned return to the operating room following deceased donor kidney transplantationPhosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench
P50
Q35207635-78FE9997-86AF-4ADF-8975-5CB5060EFC16Q35749463-F3D476BA-85D5-4709-9F87-5C76024D0449Q35854735-41D5205D-3C35-43F2-97E3-2416DD316823Q36020137-D8C4448B-98AD-4B35-BBCF-768DDCB146D9Q36551429-A639F52E-BD74-4236-BA2A-71DAD5231240Q37644538-DD492F44-BED1-4790-A823-3FD14054F4D2Q37773564-0A52D0EF-EC11-4837-8246-33DEF7098275Q37882191-ED31CE65-980C-4D87-BFBD-918F7AE9AE3EQ37906439-1B9895F3-66E4-4690-AA72-66775ACCB414Q37949509-548B147D-E2B5-4A28-A482-F549DB98E863Q37963992-EE704DBD-5651-4349-828E-D2B31C993490Q38006178-C5EA2EAB-DEA0-426E-820B-626470636146Q38010737-AA70A155-71F8-447A-A988-D535D893671BQ38039454-5849D42F-4A8E-481E-92D0-191471D1D0A7Q38072192-1108336A-1428-48C4-A2C1-C4B8C13CDCB9Q38092240-171B3BA1-C3F6-4349-B771-52C66EC2A8FFQ38145615-D52EA6B7-E07B-4CD6-8AA8-9EC52E03B802Q38151290-EC2A0D2E-D206-4EC9-A8A4-C91E6271B1E3Q38173813-8F5438E1-1359-4DF8-B681-F15779129E00Q38516516-C257B32D-F983-4BE2-9AD9-2DC00E9EEEC1Q40280114-4C291118-C3F2-4D89-8DDF-7C5B2E15CD35Q41397576-D2909AAB-959C-4F10-9FBC-C1A241C4208BQ43716692-73B957A9-4E30-451E-B654-A441B91B921CQ46183457-285990D9-7D38-424A-868D-6468D2261F8CQ46322596-22200D3D-CF00-4924-8278-86B9CF36B342Q46604017-B68D0DCD-A396-499E-B4E9-AFDD273744A6Q50667096-AD1707BF-5C87-4D6E-AAA6-C9955D3824A3Q53115442-3FE12FE8-E535-4EAE-83EC-FC643A88D964Q64136002-57DAEC60-AC05-44CC-9D19-392B109E709FQ83320688-3EE2AC1C-96C0-4672-95A8-4895C63DD7FAQ83841693-A3A6FC6A-D24B-46F5-8E1A-97A94DD98D47Q84568612-39A39CE0-8041-4ACF-910E-98E60C34845CQ84924793-76C23F7B-3154-4A0A-875C-27C7E992280FQ88560130-0E6106FF-0F3F-4657-BBC5-EBF2F44E57A0Q91256487-2E406E95-8BC0-4C76-9746-71614B0E90C1Q91972761-A0F1834E-69BD-460F-B985-F5A86E524F06
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robert M. Cannon
@ast
Robert M. Cannon
@en
Robert M. Cannon
@es
Robert M. Cannon
@nl
Robert M. Cannon
@sl
type
label
Robert M. Cannon
@ast
Robert M. Cannon
@en
Robert M. Cannon
@es
Robert M. Cannon
@nl
Robert M. Cannon
@sl
prefLabel
Robert M. Cannon
@ast
Robert M. Cannon
@en
Robert M. Cannon
@es
Robert M. Cannon
@nl
Robert M. Cannon
@sl
P106
P1153
36522288200
P21
P31
P496
0000-0002-0345-0643